President Trump has established a commission to reduce chronic disease in children and review the use of psychiatric medications, chemicals, and environmental exposures. Led by Robert F. Kennedy Jr., the commission will assess drugs like SSRIs, antipsychotics, stimulants, and weight-loss medications,
with an initial report due in 100 days and a strategy within 80 more days.While supporters see it as a step toward health reform, critics—including doctors and mental health advocates—fear it could limit access to essential medications. With mental health concerns rising, the policy’s impact remains uncertain, fueling heated debate across the country.
